| Literature DB >> 17225930 |
Emanuel C Trabuco1, Christopher J Klingele, John B Gebhart.
Abstract
Xenografts, bovine or porcine acellular collagen bioprostheses derived from dermis, pericardium, or small-intestine submucosa, were introduced to overcome synthetic mesh-related complications. Although there are eight commercially available xenografts, there is a paucity of empiric information to justify their use instead of the use of synthetic grafts. In addition, limited data are available about which graft characteristics are important and whether graft-reinforced repairs reduce recurrences and improve outcomes. To address these knowledge gaps, we conducted a Medline search of published reports on xenografts in animal and human trials. Histologic host response to implanted xenograft material depends primarily on chemical cross-linking and porosity, and it is limited to four responses: resorption, incorporation, encapsulation, and mixed. No clinical data unequivocally demonstrate an improved benefit to graft-reinforced repair.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17225930 DOI: 10.1007/s00192-006-0288-2
Source DB: PubMed Journal: Int Urogynecol J Pelvic Floor Dysfunct